Minerva Neurosciences, Inc. NERV
2.59 USD +0.24 (+10.21%)
Nov 4, 2026, 2:27 PM EST
2.39 Day range 2.61
1.96 52-week range 8.80
- YTD
- -35.57%
- 1 year
- -29.43%
Analyst view
Price target (mean) 5.00
Ratings (0m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.05 | -1.05 – -1.05 | 0.00 | 0.0% | 0 | 0.0% | 1 |
| Next quarter | -1.07 | -1.07 – -1.07 | -1.13 | +5.3% | 0 | 0.0% | 1 |
| Current year | -0.30 | -0.30 – -0.30 | -4.61 | +93.5% | 0 | 0.0% | 1 |
| Next year | -2.68 | -2.68 – -2.68 | -0.30 | -793.3% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 6, 2024 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Aug 7, 2024 | HC Wainwright & Co. | Maintained | Neutral | Neutral |
| May 2, 2024 | HC Wainwright & Co. | Maintained | Neutral | Neutral |
| Feb 27, 2024 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Aug 2, 2023 | HC Wainwright & Co. | Maintained | Neutral | Neutral |
| May 16, 2023 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| May 2, 2023 | HC Wainwright & Co. | Reiterated | — | Neutral |
| Mar 9, 2023 | HC Wainwright & Co. | Reiterated | — | Neutral |
| Nov 10, 2022 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Oct 17, 2022 | JMP Securities | Downgrade | Market Outperform | Market Perform |